CSS »

Engene Therapeutics shares owned by CSS

Quarter-by-quarter ownership of Engene Therapeutics shares owned by CSS from 13F filings

Historical chart of CSS investment in Engene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Engene Therapeutics held by CSS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Therapeutics by CSS

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.9k 17k 0.29

More positions owned by CSS

Lumentum Hldgs Note 0.500% 6/1 (Principal)
Hewlett Packard Enterprise C 7.625 Mand Conv (HPE.PC)
Echostar Corp Note 3.875%11/3 (Principal)
Apollo Global Mgmt Ser A Mand Cnv (APO.PA)
Bank Of Amer Corp 7.25%CNV PFD L (BAC.PL)
Wolfspeed Note 2.500% 6/1 (Principal)
Super Micro Computer 7 Dep Cm Sr A Wi
Core Scientific *w Exp 01/23/202 (CORZW)
Microchip Technology Dep Shs Repstg (MCHPP)
Cloudflare Note 8/1 (Principal)
Akamai Technologies Note 1.125% 2/1 (Principal)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Gamestop Corp Cl A (GME)
Albemarle Corp 7.25% Dep Shs A (ALB.PA)
Centerpoint Energy Note 4.250% 8/1 (Principal)

View all positions for CSS

Top funds holding Engene Therapeutics

BVF
Blue Owl Capital Holdings
Caption Management
LMR Partners
Aristeia Capital
D. E. Shaw & Co
Millennium Management
Toronto-Dominion Bank
CSS
Intl Fcstone
Clear Street Group

View all funds holding Engene Therapeutics